Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Quantitative Computed Tomography Assessment of the Effects of 24 months of Teriparatide Treatment on 3-D Femoral Neck Bone Distribution, Geometry and Bone Strength: Results from the EUROFORS Study
Journal of Bone and Mineral Research, 10/01/09
Borggrefe J et al. – FN QCT provides a tool for detailed longitudinal investigation of bone strength indices in vivo for different loading modes, yields insight into underlying structural changes and provides relevant mechano–structural information beyond DXA. Continuous TPTD treatment for 24 months improves FN bone strength parameters.
Related Articles
Teriparatide Outperforms Alendronate In Treating Steroid-induced Osteoporosis
ScienceDaily, 10/30/09
Relevance Score: 87%
Successful treatment of sternal fracture nonunion with teriparatide
Osteoporosis International, 10/30/09
Relevance Score: 87%
Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: Results from quantitative computed tomography-based finite element analysis of the vertebral body
Bone, 10/27/09
Relevance Score: 87%
Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
Arthritis & Rheumatism, 11/03/09
Relevance Score: 84%
Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis
Journal of Bone and Mineral Metabolism, 10/13/09
Relevance Score: 84%
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
The Role of Quantitative Bone Scanning in the Assessment of Bone Turnover in Patients with Charcot Foot
Diabetes Care, 11/25/09
The Shifting Trajectory of Growth in Femur Length During Gestation
Journal of Bone and Mineral Research, 11/25/09
Assessment of Regional Changes in Skeletal Metabolism Following 3 and 18 Months of Teriparatide Treatment
Journal of Bone and Mineral Research, 11/25/09
Today in Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Limited Value of 18F-F-DOPA PET to Localize Pancreatic Insulin-Secreting Tumors in Adults with Hyperinsulinemic Hypoglycemia
Journal of Clinical Endocrinology and Metabolism, 11/25/09
A Comparison Between Diagnostic I-123 and Posttherapy I-131 Scans in the Detection of Remnant and Locoregional Thyroid Disease
Clinical Nuclear Medicine , 11/25/09
F-18 FDG-PET/CT Evaluation of Patients With Differentiated Thyroid Cancer With Negative I-131 Total Body Scan and High Thyroglobulin Level
Clinical Nuclear Medicine , 11/25/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
International Journal of Obesity, 11/25/09
Assessment of Regional Changes in Skeletal Metabolism Following 3 and 18 Months of Teriparatide Treatment
Journal of Bone and Mineral Research, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


